Ovalbumin/lipopolysaccharide induced vasculitis in rats: a new predictive model

Area of Science:

• Immunology
• Pathology
• Animal Models

Background:

• Vasculitis research requires robust animal models.
• Ovalbumin (OVA) and lipopolysaccharide (LPS) are known inflammatory agents.
• The specific role of OVA and LPS in inducing vasculitis remains underexplored.

Purpose of the Study:

• To develop and validate a novel animal model for vasculitis using OVA and LPS in rats.
• To investigate the dose-dependent effects of OVA/LPS on vascular inflammation and related biomarkers.

Main Methods:

• 42 Wistar rats were randomly assigned to control or OVA/LPS treatment groups at varying doses (0.5, 1, 5 mg/kg).
• Animals received either intraperitoneal sensitization or sensitization plus a one-week intranasal challenge.
• Key inflammatory markers, organ function, and damage indicators were assessed.

Main Results:

• OVA/LPS administration significantly elevated circulating inflammatory cells, C-reactive protein (CRP), and inflammatory cytokines (IL-1β, IL-6, TNF-α) in a dose-dependent manner.
• Kidney damage markers (BUN, Creatinine) and liver function enzymes (AST, ALT) also showed significant, dose-dependent increases.
• A 5 mg/kg dose of OVA/LPS resulted in severe vascular inflammation.

Conclusions:

• Ovalbumin and lipopolysaccharide effectively induce vascular inflammation in a dose-dependent pattern in rats.
• The 5 mg/kg dose of OVA/LPS demonstrated significant potential in creating severe vascular inflammation.
• This study proposes OVA/LPS as a viable new animal model for studying vasculitis.